Vaccines

Establishing both efficient and safe manufacturing processes for biosimilars requires planning, expertise, and state-of-the-art equipment. In this article, we will shed light on different steps in the manufacturing process and discuss ways to improve them.

Freezing and thawing are essential steps in the cold chain management of biosimilars. With several methods eligible, we have chosen some prominent ones, explaining their advantages, limitations, and our preferred choices.

Over the years, several biosimilars have been approved as alternatives for often more costly biologics. We have listed them, along with the product they refer to.

Biosimilars are a popular alternative to reference biologics they resemble. But what has led to this popularity, and what’s to know about their manufacturing? Find out in this article!

In the past few decades, biologics have become an integral pillar in healthcare worldwide. Deriving from living organisms, they hold huge therapeutic potential, with many possible applications still undiscovered. In this article, we will give you an overview of this exciting class of pharmaceuticals.

Once biologics are produced, they need to be stored for shorter or longer periods of time, with dedicated storage requirements to be met. Here, we will uncover these requirements, along with solutions to fulfill them.

Biologics and biosimilars are both innovative and frequently used therapeutics, but where do they differ? They will be uncovered in this article.

There is more than one way to prepare biologics for long-term storage under temperature-controlled conditions – in this article, we will explore some of the main freezing methods.

cGMP plays a fundamental role in several stages of vaccine manufacturing. In this article, we will examine this role in more detail, including its manifold implications for vaccine manufacturers.

Ultra low temperature (ULT) storage emerges as a solid rock to safeguard the cold chain. Discover cutting-edge technologies, the role of controlled freezing, and Single Use Support's solution for long-term storage of vaccines.

Vaccine development and manufacturing are a challenging business and in order to be efficient and successful manufacturers will have to adopt advanced technologies. The obstacles are manifold and the fragility of supply chains or requirements in cold chain management are just two of the challenges in vaccine manufacturing.

Scale-up in vaccine management comes with various intricacies. In this article, we will uncover some of them, along with solutions to overcome them.